Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Stutterson Nov 08, 2022 11:40pm

311 Views

Post# 35084170

Pez

i missed you buddy. Glad you are doing fine. Say whats you average now? Im sure its .48 cents like the rest of the pumper clown crew. Im going to buy a little at 30 cents. After the recession is in. Mugsy has been posting lots so I think it will hit .30's no problem. I might put a big order in when management decides to buy some. It doesnt look promising when the owners and insiders arent betting on their own abilities......im not even talking a win..just to .make say....40%. . But nothing. Pez, have a wonderful day. Im sorry for naking fun of you in tbe past. Im glad you stopped emailing me those 'awkward' photos. Thank you.

<< Previous

Bullboard Posts

Next >>

NervGen: Are amazing human trial results leaking out?